![Barbara Angehrn Pavik](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Barbara Angehrn Pavik
Direttore/Membro del Consiglio presso BELLEVUE GROUP AG
Patrimonio netto: 1 M $ in data 31/05/2024
Profilo
Barbara Angehrn Pavik is the founder of STEPSTONE Pharma GmbH.
She is currently the Chief Executive Officer at Asceneuron SA, an Independent Director at Bellevue Group AG, and an Independent Non-Executive Director at medmix AG.
Previously, she worked at Vifor Pharma AG as an Executive Director & Chief Business Officer.
She graduated from the University of St. Gallen.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
BELLEVUE GROUP AG
0.40% | 31/12/2023 | 54 000 ( 0.40% ) | 1 M $ | 31/05/2024 |
Posizioni attive di Barbara Angehrn Pavik
Società | Posizione | Inizio |
---|---|---|
BELLEVUE GROUP AG | Direttore/Membro del Consiglio | 21/03/2023 |
MEDMIX AG | Direttore/Membro del Consiglio | 01/04/2022 |
Asceneuron SA
![]() Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Amministratore Delegato | 06/10/2023 |
Precedenti posizioni note di Barbara Angehrn Pavik
Società | Posizione | Fine |
---|---|---|
STEPSTONE Pharma GmbH
![]() STEPSTONE Pharma GmbH Pharmaceuticals: MajorHealth Technology STEPSTONE Pharma GmbH manufactures and wholesales pharmaceutical products. It in-licenses and commercializes pharmaceutical products ex-US. The company was founded by Barbara Angehrn in October 2013 and is headquartered in Zurich, Switzerland. | Amministratore Delegato | - |
VIFOR PHARMA | Direttore/Membro del Consiglio | - |
Formazione di Barbara Angehrn Pavik
University of St. Gallen | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BELLEVUE GROUP AG | Finance |
MEDMIX AG | Health Technology |
Aziende private | 3 |
---|---|
Vifor Pharma AG
![]() Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The firm offers products for iron deficiency, nephrology, and cardio-renal therapies. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland. | Health Technology |
STEPSTONE Pharma GmbH
![]() STEPSTONE Pharma GmbH Pharmaceuticals: MajorHealth Technology STEPSTONE Pharma GmbH manufactures and wholesales pharmaceutical products. It in-licenses and commercializes pharmaceutical products ex-US. The company was founded by Barbara Angehrn in October 2013 and is headquartered in Zurich, Switzerland. | Health Technology |
Asceneuron SA
![]() Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Barbara Angehrn Pavik